Novavax finally won approval of a Covid-19 vaccine after facing setback after setback that caused the stock to plunge more ...

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...

Key Takeaways The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine for certain groupsOnly adults 65+ or ...

In the options pits, NVAX has already seen quadruple the overall options volume it typically sees in an entire session, with ...